The information and data that are being gathered about Covid-19 across the world are turning into one of the keys to its analysis and study, crucial for the prevention and monitoring of new infections and the improvement of everyone’s general health. These data are helping healthcare professionals, researchers, and epidemiologists to have a better understanding of the virus.
It is a fact that COVID-19 has transformed the way we live and our relationship with our environment. Our routines and our daily lives have been changed completely in the last few weeks so that we can avoid infection with the disease. Even today we continue with constant transformation.
Our technology is being used by more than 100 hospitals in multiple high-impact initiatives related to COVID-19. We have been able to quickly adapt our technological ecosystem to the huge challenges presented by this global crisis, undertaking projects in collaboration with clinical professionals, researchers, and organizations in the healthcare field.
Since it appeared in China in the middle of December, coronavirus has created significant consequences for the global population which are still evident today. Because of that, the scientific and healthcare communities are working every day to gather information about this virus and its disease that will help them determine the best way of combatting it.
EPICOS: The COVID Clinical Trial promoted by the Ministry of Health and implemented using our technology ReseaArch®
Last Wednesday in the Congress of Deputies, the Minister of Health, Salvador Illa, announced the launch of the EPICOS Clinical Trial, promoted by the Ministry of Health for the prevention of coronavirus infection in healthcare. We are proud that our clinical trial system, ReseaArch®, has been chosen for the implementation of this clinical trial.
As we all know, for weeks Spain has been immersed in a quarantine in order to contain and avoid the spread of the COVID-19 virus (coronavirus). This disease has already been found in more than 200 countries or territories, affecting more than 750,000 people (according to the World Health Organization).